TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
FrostPharma AB
Closing information (x1000 SEK)
| Closing information | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Turnover |
297,071
|
183,010
|
139,364 |
| Financial expenses |
6,023
|
2,958
|
2,118 |
| Earnings before taxes |
7,676
|
14,005
|
28,310 |
| EBITDA |
25,065
|
18,301
|
31,106 |
| Total assets |
405,481
|
127,197
|
100,238 |
| Current assets |
178,963
|
119,234
|
91,951 |
| Current liabilities |
84,718
|
43,730
|
67,724 |
| Equity capital |
185,351
|
42,154
|
31,244 |
| - share capital |
60
|
60
|
58 |
| Employees (average) |
26
|
15
|
10 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Solvency |
45.7%
|
33.1%
|
31.2% |
| Turnover per employee |
11,426
|
12,201
|
13,936 |
| Profit as a percentage of turnover |
2.6%
|
7.7%
|
20.3% |
| Return on assets (ROA) |
3.4%
|
13.3%
|
30.4% |
| Current ratio |
211.2%
|
272.7%
|
135.8% |
| Return on equity (ROE) |
4.1%
|
33.2%
|
90.6% |
| Change turnover | |||
| Change turnover % |
31%
|
76% | |
| Chg. No. of employees | |||
| Chg. No. of employees % |
50%
|
25% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.